Leave a message

Investigating the Healing Potential of Topical Phenytoin for Therapeutic Treatment in Thermal Burns

Case Report | DOI: https://doi.org/10.31579/2693-4779/207

Investigating the Healing Potential of Topical Phenytoin for Therapeutic Treatment in Thermal Burns

  • Karthikeyan 1
  • Ravi Kumar Chittoria 2*
  • Jacob Antony Chakiath 3
  • Kanav Gupta 4

1MBBS, MS Orthopaedics surgery Junior Resident Department of Orthopaedic Surgery JIPMER Puducherry India – 605006
2Senior Professor Head of IT Wing and Telemedicine Department of Plastic Surgery & Telemedicine JIPMER Pondicherry India – 605006
3MBBS MS General Surgery Senior Resident Department of Plastic Surgery JIPMER Puducherry India – 605006
4MBBS, MS DNB General Surgery Senior Resident Department of Plastic Surgery JIPMER Puducherry India – 605006
 

*Corresponding Author: Ravi Kumar Chittoria, Senior Professor Head of IT Wing and Telemedicine Department of Plastic Surgery & Telemedicine JIPMER Pondicherry India.

Citation: Karthikeyan, Ravi K. Chittoria, Jacob A. Chakiath, Kanav Gupta, (2024), Investigating the Healing Potential of Topical Phenytoin for Therapeutic Treatment in Thermal Burns, Clinical Research and Clinical Trials, 10(3); DOI:10.31579/2693-4779/207

Copyright: © 2024, Ravi Kumar Chittoria. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 06 May 2024 | Accepted: 03 June 2024 | Published: 22 July 2024

Keywords: Topical phenytoin therapy; regenerative therapy; wound management

Abstract

Thermal burn injuries impose significant physical and psychological distress, particularly in underdeveloped regions. Facilitating early wound healing is paramount to mitigate ensuing complications. Phenytoin, easily accessible, has emerged as a potential agent for expediting wound recovery. This study endeavors to assess the therapeutic efficacy of topical phenytoin in second and third-degree burn injuries. The research involved a 70-year-old female with thermal burns affecting both gluteal regions. Intravenous phenytoin solution was topically applied every two days. Data collection encompassed demographic details, tissue culture findings, wound discharge, pain intensity, granulation tissue formation, and wound contraction. Self-inflicted burns predominated the cases examined. Despite initial colonization with pathogenic bacteria, phenytoin treatment did not impede wound healing. Following 2-4 sessions, a significant reduction in wound discharge and pain relief were observed. Digital planimetry demonstrated progressive wound contraction across all cases. In conclusion, topical phenytoin application demonstrated efficacy in promoting wound contraction, re-epithelialization, and alleviating pain, thereby expediting wound healing. Furthermore, some cases exhibited a bacteriostatic effect. Nevertheless, further rigorous trials are imperative to validate these findings.

Introduction

Burn injuries present notable physiological and psychological hurdles, necessitating specialized interventions including fluid regulation, electrolyte monitoring, wound management, respiratory and nutritional support, infection control, and in severe cases, addressing sepsis and multiple organ failure. Accelerating wound recovery is paramount to mitigate burn-related complications like hypertrophic scarring and joint contractures. Evaluation of burn severity, typically done via the rule of nines or Lund and Browder chart, guides fluid and nutritional therapy. Assessing burn depth is crucial for determining appropriate conservative or surgical measures, distinguishing between epidermal, superficial partial-thickness, deep partial-thickness, and full-thickness burns. Effective burn care mandates a thorough evaluation, assessment, and treatment approach. While superficial and partial-thickness burns may resolve spontaneously, deeper burns often require prompt surgical intervention to prevent complications and prepare the wound bed for tissue coverage. Infection stands as a primary culprit for morbidity and mortality in extensive burns, leading to delayed healing and systemic infections. Diverse topical therapies, ranging from antibiotic creams to silver/iodine-releasing dressings, are utilized in burn wound management. Moreover, certain medications like insulin and phenytoin, originally designed for unrelated conditions, exhibit wound-healing properties and are increasingly utilized in burn care. Phenytoin, initially indicated for seizure management1,2, is linked with gingival overgrowth3 and mild skin and skull thickening, suggesting its potential in wound healing due to its impact on connective tissue stimulation.

Material and Methods

The research was conducted at the JIPMER tertiary burn care center, focusing on a 70-year-old female presenting with thermal burns affecting the gluteal region (Figure 1). Topical phenytoin therapy was initiated within 48 hours post-admission (Figure 2). Prior to commencing phenytoin therapy, the surface area of the raw wound was assessed using digital planimetry software, and tissue cultures were obtained. Topical phenytoin was applied every third day until the patient's discharge, skin grafting, or resolution of the burn wound. Intravenous phenytoin solution, ranging from 100-300 mg (50mg/1ml), was dispersed over the wound surface and covered with Vaseline gauze dressings. Patients underwent monitoring for wound discharge, pain intensity, granulation tissue formation, and wound contraction every three days. Additional systemic support, such as nutritional supplementation, antibiotics, and analgesics, was administered as deemed necessary for individual patient care.

Figure 1: showing condition of thermal burns over gluteal region at time of presentation

Figure 2 showing application of phenytoin solution over the thermal burns

Figure 3: showing improvement in condition of thermal burns three sessions after application of topical phenytoin solution

Results

This investigation involved a 70-year-old female with thermal burns encompassing approximately 15% of her body surface area, primarily due to accidental injuries affecting the gluteal region. Intravenous phenytoin solution was administered over 5-7 sessions. Substantial progress in wound healing was evident, characterized by heightened granulation tissue formation and re-epithelialization, assessed through digital planimetry software to quantify wound contraction (Figure 3). Gradual reduction in wound discharge from moderate to mild was observed, alongside a notable decrease in subjective pain perception from severe to mild/no pain. Complete 
wound healing was achieved through secondary intention. She reported experiencing a mild burning sensation during phenytoin application, lasting only briefly. No systemic or local adverse effects were documented in this patient.

Discussion

Phenytoin, primarily acknowledged for its antiepileptic attributes, has emerged as a promising agent in fostering wound healing across a spectrum of conditions, including diabetes ulcers, decubitus ulcers4,5, traumatic ulcers7,8, venous ulcers6, tuberculous ulcers, epidermolysis bullosa, and burns9. Its multifaceted mechanisms encompass augmentation of neovascularization, proliferation of myofibroblasts and fibroblasts, synthesis and deposition of collagen, extracellular matrix assembly, and modulation of growth factors10 and their mediators. Phenytoin exerts additional benefits by mitigating edema, wound exudate, bacterial load, and pain, while facilitating re-epithelialization. Although the exact mechanism remains elusive, it is postulated to involve the upregulation of platelet-derived growth factor gene expression in monocytes and macrophages, alongside an overall inhibitory impact on collagenase. The topical administration of phenytoin ensures targeted delivery to the wound site while minimizing systemic repercussions. Diverse formulations, including powdered tablets, saline or IV solutions, creams, ointments, lotions, and aerosols, are available for wound application. Investigations by Firmino et al. have elucidated the advantageous effects of topical phenytoin in wound healing and grafting preparation across various ulcer types. Carneiro et al.'s comparative research has underscored the efficacy of topical phenytoin versus silver sulfadiazine in acute burn treatment, emphasizing substantial pain reduction with phenytoin application. Furthermore, another prospective randomized study by Carneiro et al. has emphasized the favorable effects of topical phenytoin in expediting wound healing, diminishing pain and discharge in chronic leg ulcers, findings in line with observations in acute burn wound management.

Conclusion

Our study delved into the adjunctive use of topically administered phenytoin, revealing a notable progression in wound contracture, re-epithelialization, diminished discharge, and alleviated pain, collectively expediting the process of wound healing. Moreover, select cases exhibited a bacteriostatic effect. Nevertheless, it is paramount to conduct additional controlled trials to validate these observations and ascertain the efficacy of phenytoin as an adjunctive intervention in wound management.

 

References

a